Ying Ou

1.7k total citations
62 papers, 1.2k citations indexed

About

Ying Ou is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Ying Ou has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 23 papers in Hematology and 20 papers in Genetics. Recurrent topics in Ying Ou's work include Chronic Lymphocytic Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Multiple Myeloma Research and Treatments (10 papers). Ying Ou is often cited by papers focused on Chronic Lymphocytic Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Multiple Myeloma Research and Treatments (10 papers). Ying Ou collaborates with scholars based in China, United States and Australia. Ying Ou's co-authors include Weijia Liao, Jian Huang, Xing Liu, Srikumar Sahasranaman, Rafael Ponce, Elaine M. Faustman, Yanggu Shi, Wei Wang, Zhiyu Tang and Jon Patrick and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Blood.

In The Last Decade

Ying Ou

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Ou China 21 609 213 188 176 147 62 1.2k
Jiajun Liu China 17 390 0.6× 162 0.8× 115 0.6× 171 1.0× 49 0.3× 68 1.3k
Yihui Shi United States 21 841 1.4× 66 0.3× 144 0.8× 493 2.8× 66 0.4× 50 1.8k
Ling Lu China 22 823 1.4× 471 2.2× 146 0.8× 503 2.9× 137 0.9× 64 1.8k
Bart J. Crielaard Netherlands 18 463 0.8× 304 1.4× 215 1.1× 91 0.5× 22 0.1× 24 1.3k
Jing Ge China 19 275 0.5× 213 1.0× 95 0.5× 84 0.5× 75 0.5× 82 931
Xiaoyan Wang China 20 427 0.7× 53 0.2× 55 0.3× 353 2.0× 32 0.2× 92 1.5k
Valérie André United States 24 638 1.0× 43 0.2× 146 0.8× 525 3.0× 61 0.4× 103 1.9k
Wen‐Bin Ou China 27 862 1.4× 165 0.8× 76 0.4× 427 2.4× 205 1.4× 64 2.9k
Yikai Zhang China 17 421 0.7× 108 0.5× 61 0.3× 529 3.0× 67 0.5× 52 1.4k
Yueying Li China 19 462 0.8× 136 0.6× 191 1.0× 108 0.6× 55 0.4× 83 959

Countries citing papers authored by Ying Ou

Since Specialization
Citations

This map shows the geographic impact of Ying Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Ou more than expected).

Fields of papers citing papers by Ying Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Ou. The network helps show where Ying Ou may publish in the future.

Co-authorship network of co-authors of Ying Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Ou. A scholar is included among the top collaborators of Ying Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Ou. Ying Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ou, Ying, et al.. (2025). Bioinformatics‐Driven Design of Peptides for Membrane Stabilization During Cryopreservation. Angewandte Chemie International Edition. 64(49). e202516336–e202516336.
3.
Demin, Oleg, et al.. (2025). Quantitative Systems Pharmacology Model to Predict Target Occupancy by Bruton Tyrosine Kinase Inhibitors in Patients With B‐Cell Malignancies. CPT Pharmacometrics & Systems Pharmacology. 14(4). 706–717. 1 indexed citations
4.
Tam, Constantine S., Mazyar Shadman, Jeff P. Sharman, et al.. (2023). PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES. HemaSphere. 7(S3). e70124b5–e70124b5. 1 indexed citations
5.
6.
7.
Ludwig, Heinz, Andrew Spencer, Tibor Kovacsovics, et al.. (2017). Comparison of Proteasome Inhibition Activity between Carfilzomib and Bortezomib in the Phase 3 Endeavor Study. Blood. 130. 3125–3125. 4 indexed citations
8.
Quach, Hang, Darrell White, Andrew Spencer, et al.. (2017). Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study. Cancer Chemotherapy and Pharmacology. 79(6). 1067–1076. 18 indexed citations
9.
Ou, Ying & Jon Patrick. (2015). Automatic negation detection in narrative pathology reports. Artificial Intelligence in Medicine. 64(1). 41–50. 12 indexed citations
10.
Liu, Xing, Weijia Liao, Qing Yuan, Ying Ou, & Jian Huang. (2015). TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells. Oncotarget. 6(33). 34309–34320. 79 indexed citations
11.
Ou, Ying & Jon Patrick. (2014). Automatic Structured Reporting from Narrative Cancer Pathology Reports. 8(2). 20. 6 indexed citations
12.
Hu, Xueda, Shengqing Wan, Ying Ou, et al.. (2014). RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencing. Cancer Letters. 357(2). 510–519. 36 indexed citations
13.
Patrick, Jon, et al.. (2013). ShARe/CLEF eHealth 2013 Normalization of Acronyms/Abbreviations Challenge. CLEF (Working Notes). 4 indexed citations
14.
Patrick, Jon, et al.. (2013). ShARe/CLEF eHealth 2013 Named Entity Recognition and Normalization of Disorders Challenge. CLEF (Working Notes). 3 indexed citations
15.
Liu, Xingrong, et al.. (2013). Pharmacokinetics and Pharmacodynamics of CD4-Anchoring Bi-Functional Fusion Inhibitor in Monkeys. Pharmaceutical Research. 31(3). 809–818. 3 indexed citations
16.
Liao, Weijia, Weilong Liu, Qing Yuan, et al.. (2013). Silencing of DLGAP5 by siRNA Significantly Inhibits the Proliferation and Invasion of Hepatocellular Carcinoma Cells. PLoS ONE. 8(12). e80789–e80789. 73 indexed citations
17.
Zhong, Chen, et al.. (2012). Crystal Structures of Human CaMKIα Reveal Insights into the Regulation Mechanism of CaMKI. PLoS ONE. 7(9). e44828–e44828. 10 indexed citations
18.
Guo, Qing, Yichun Zhang, Biao Yu, et al.. (2008). Molecular Mechanism of ADP-Ribose Hydrolysis By Human NUDT5 From Structural and Kinetic Studies. Journal of Molecular Biology. 379(3). 568–578. 31 indexed citations
19.
Liu, Hui, Chuanbing Zhu, Jian Luo, et al.. (2004). ZNF411, a novel KRAB-containing zinc-finger protein, suppresses MAP kinase signaling pathway. Biochemical and Biophysical Research Communications. 320(1). 45–53. 37 indexed citations
20.
Faustman, Elaine M., et al.. (2002). Investigations of methylmercury-induced alterations in neurogenesis.. Environmental Health Perspectives. 110(suppl 5). 859–864. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiajun Liu Breakdown of academic impact, for papers by Yihui Shi Breakdown of academic impact, for papers by Ling Lu Breakdown of academic impact, for papers by Bart J. Crielaard Breakdown of academic impact, for papers by Jing Ge Breakdown of academic impact, for papers by Xiaoyan Wang Breakdown of academic impact, for papers by Valérie André Breakdown of academic impact, for papers by Wen‐Bin Ou Breakdown of academic impact, for papers by Yikai Zhang Breakdown of academic impact, for papers by Yueying Li
Rankless by CCL
2026